IRTC - iRhythm Technologies Inc. (IRTC) Q4 2023 Earnings Call Transcript

2024-02-22 20:58:11 ET

iRhythm Technologies, Inc. (IRTC)

Q4 2023 Earnings Conference Call

February 22, 2024, 4:30 PM ET

Company Participants

Stephanie Zhadkevich - Director, Investor Relations

Quentin Blackford - President and CEO

Brice Bobzien - Chief Financial Officer

Dan Wilson - Executive Vice President, Corporate Development and IR

Conference Call Participants

Allen Gong - JPMorgan

David Saxon - Needham

Marie Thibault - BTIG

Nathan Treybeck - Wells Fargo

John Young - Canaccord

David Rescott - Baird

Michael Polark - Wolfe Research

Shaymus Contorno - Oppenheimer

Presentation

Operator

Good afternoon. And thank you for joining the iRhythm Technologies Q4 2023 Earnings Conference Call. At this time, all lines are in a listen-only mode and will be until the question-and-answer session at the end.

I would now like to turn the call over to Stephanie Zhadkevich, Director of Investor Relations at iRhythm. You may proceed.

Stephanie Zhadkevich

Thank you all for participating in today’s call. Earlier today, iRhythm released financial results for the fourth quarter and full year ended December 31, 2023.

Before we begin, I’d like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

Any statements contained in this call that are not statements of historical fact should be deemed to be forward-looking statements. These are based upon our current estimates and various assumptions and reflect management’s intentions, beliefs and expectations about future events, strategies, competition, products, operating plans and performance.

These statements involve risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements.

For a list and description of the risks and uncertainties associated with our business, please refer to the risk factors section of our most recent annual and quarterly report on Form 10-K and Form 10-Q, respectively, filed with the Securities and Exchange Commission.

Also during the call, we will discuss certain financial measures that have not been prepared in accordance with U.S. GAAP with respect to our non-GAAP and cash-based results, including adjusted EBITDA, adjusted operating expenses and adjusted net loss.

Unless otherwise noted, all references to financial metrics are presented on a non-GAAP basis. The presentation of this additional information should not be considered in isolation of, as a substitute for, or superior to results prepared in accordance with GAAP.

Please refer to the tables in our earnings release and 10-K for a reconciliation of these measures to their most directly comparable GAAP financial measures. Unless otherwise noted, all references to financial measures in this call, other than revenue, refer to non-GAAP results....

For further details see: